SARISSA CAPITAL MANAGEMENT LP – BioCryst Pharmaceuticals, Inc. Transaction History
SARISSA CAPITAL MANAGEMENT LP portfolio value:
$17.52M
portfolio value
SARISSA CAPITAL MANAGEMENT LP quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 2.80M | $12.6 | 1.39M | |
| Q2 2022 | share | 0.00% | 0 shares | -7.89M | $10.58 | 1.39M | |
| Q1 2022 | share | Decrease | -65.57% | -2.64M shares | -33.33M | $16.26 | 1.39M |
| Q4 2021 | share | Increase | +2.88% | 112.9K shares | -479K | $13.79 | 4.03M |
| Q3 2021 | share | Decrease | -7.85% | -334.3K shares | -10.93M | $14.37 | 3.92M |
| Q2 2021 | share | Decrease | -44.21% | -3.37M shares | -10.30M | $15.81 | 4.26M |
| Q1 2021 | share | Decrease | -6.57% | -537.3K shares | 16.77M | $10.17 | 7.63M |
| Q4 2020 | share | Increase | +68.18% | 3.31M shares | 44.20M | $7.45 | 8.17M |
| Q3 2020 | share | Increase | +352.19% | 3.78M shares | 11.57M | $3.44 | 4.86M |
| Q2 2020 | share | Increase | 0.00% | 1.07M shares | 5.12M | $4.76 | 1.07M |